The stock of Hims & Hers Health Inc (NYSE:HIMS) last traded at $20.50, up 9.68% from the previous session.
HIMS stock price is now 24.06% away from the 50-day moving average and 32.82% away from the 200-day moving average. The market capitalization of the company currently stands at $4.44B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $24, Needham recently initiated with Buy rating for Hims & Hers Health Inc (NYSE: HIMS). , while ‘Citigroup’ rates the stock as ‘Neutral’
In other news, Baird Melissa, Chief Operating Officer sold 58,750 shares of the company’s stock on Oct 07 ’24. The stock was sold for $1,149,625 at an average price of $19.57. Upon completion of the transaction, the Chief Operating Officer now directly owns 630,166 shares in the company, valued at $12.92 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 07 ’24, Chief Financial Officer Okupe Oluyemi sold 9,868 shares of the business’s stock. A total of $196,992 was realized by selling the stock at an average price of $19.96. This leaves the insider owning 195,988 shares of the company worth $4.02 million. A total of 19.67% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $25.74. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.68, and a quick ratio of 2.30. The fifty day moving average price for HIMS is $16.5244 and a two-hundred day moving average price translates $15.43425 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-06-30. The net profit margin was 1.70% and return on equity was 5.31% for HIMS. The company reported revenue of $315.65 million for the quarter, compared to $207.91 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 51.82 percent.
